Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?

被引:25
作者
Abolhassani, Hasssan [1 ,2 ]
Asgardoon, Mohammad Hossein [1 ]
Rezaei, Nima [1 ,3 ,4 ]
Hammarstrom, Lennart [2 ]
Aghamohammadi, Asghar [1 ]
机构
[1] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran, Iran
[2] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Div Clin Immunol, Stockholm, Sweden
[3] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[4] Univ Tehran Med Sci, Mol Immunol Res Ctr, Tehran, Iran
关键词
formulations; intravenous immunoglobulin; primary immunodeficiency disease; risk factors; COMMON VARIABLE IMMUNODEFICIENCY; PRIMARY ANTIBODY DEFICIENCIES; PRIMARY IMMUNE-DEFICIENCY; REPLACEMENT THERAPY; GAMMA-GLOBULIN; SUBCUTANEOUS IMMUNOGLOBULIN; PRIMARY HYPOGAMMAGLOBULINEMIA; IMMUNOLOGICAL FEATURES; IRANIAN PATIENTS; ADVERSE EVENTS;
D O I
10.1586/1744666X.2015.1079485
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin (IG) replacement therapy has served as lifesaving treatment in primary immunodeficiency diseases (PID) for more than six decades. Approximately 70% of patients with PID require IG replacement to maintain their health during the course of disease. It is estimated that about one-third of IG products is used for replacement therapy in these patients. On the other hand, the introduction of newer IG preparations is continuing to improve and extend the quality of life in PID patients. Because of the options available including concentrations, formulations, osmolality, product stabilizers, sodium concentration, anti-infective activity, IgA content and pH, it is important to match the PID patient's complications with potential side effects associated with the composition of a particular IG product. The purpose of this review is to present the clinical differences of intravenous IG among the various preparations regarding PID patients.
引用
收藏
页码:1229 / 1243
页数:15
相关论文
共 97 条
[1]  
Abolhassani H, 2014, IRAN J IMMUNOL, V11, P123, DOI IJIv11i2A7
[2]   Home-Based Subcutaneous Immunoglobulin Versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: Systematic Review and Meta Analysis [J].
Abolhassani, Hassan ;
Sadaghiani, Mohammad Salehi ;
Aghamohammadi, Asghar ;
Ochs, Hans D. ;
Rezaei, Nima .
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (06) :1180-1192
[3]   Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency [J].
Aghamohammadi, A ;
Farhoudi, A ;
Moin, M ;
Rezaei, N ;
Kouhi, A ;
Pourpak, Z ;
Yaseri, N ;
Movahedi, M ;
Gharagozlou, M ;
Zandieh, F ;
Yazadni, F ;
Arshi, S ;
MohammadZadeh, I ;
Ghazi, BM ;
Mahmoudi, M ;
Tahaei, S ;
Isaeian, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (07) :825-832
[4]   Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia [J].
Aghamohammadi, A ;
Moin, M ;
Farhoudi, A ;
Rezaei, N ;
Pourpak, Z ;
Movahedi, M ;
Gharagozlou, M ;
Nabavi, M ;
Shahrokhi, A .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (02) :113-118
[5]  
Aghamohammadi A, 2010, J INVEST ALLERG CLIN, V20, P442
[6]   Mortality and morbidity in common variable immunodeficiency [J].
Aghamohammadi, Asghar ;
Pouladi, Nima ;
Parvaneh, Nima ;
Yeganeh, Mehdi ;
Movahedi, Masoud ;
Gharagolou, Mohamad ;
Pourpak, Zahra ;
Rezaei, Nima ;
Salavati, Ali ;
Abdollahzade, Sina ;
Moin, Mostafa .
JOURNAL OF TROPICAL PEDIATRICS, 2007, 53 (01) :32-38
[7]   Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry [J].
Aghamohammadi, Asghar ;
Mohammadinejad, Payam ;
Abolhassani, Hassan ;
Mirminachi, Babak ;
Movahedi, Masoud ;
Gharagozlou, Mohammad ;
Parvaneh, Nima ;
Zeiaee, Vaheid ;
Mirsaeed-Ghazi, Bahram ;
Chavoushzadeh, Zahra ;
Mahdaviani, Alireza ;
Mansouri, Mahboubeh ;
Yousefzadegan, Sedigheh ;
Sharifi, Bahareh ;
Zandieh, Fariborz ;
Hedayat, Ehsan ;
Nadjafi, Ali ;
Sherkat, Roya ;
Shakerian, Behzad ;
Sadeghi-Shabestari, Mahnaz ;
Hosseini, Reza Farid ;
Jabbari-Azad, Farahzad ;
Ahanchian, Hamid ;
Behmanesh, Fatemeh ;
Zandkarimi, Mohammadreza ;
Shirkani, Afshin ;
Cheraghi, Taher ;
Fayezi, Abbas ;
Mohammadzadeh, Iraj ;
Amin, Reza ;
Aleyasin, Soheila ;
Moghtaderi, Mojgan ;
Ghaffari, Javad ;
Arshi, Saba ;
Javahertrash, Naser ;
Nabavi, Mohammad ;
Bemanian, Mohammad Hassan ;
Shafiei, Alireza ;
Kalantari, Najmedin ;
Ahmadiafshar, Akefeh ;
Khazaei, Hossein Ali ;
Atarod, Lida ;
Rezaei, Nima .
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (04) :478-490
[8]   Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia [J].
Aghamohammadi, Asghar ;
Allahverdi, Abdolreza ;
Abolhassani, Hassan ;
Moazzami, Kasra ;
Alizadeh, Hooman ;
Gharagozlou, Mohammad ;
Kalantari, Najmoddin ;
Sajedi, Vahid ;
Shafiei, Alireza ;
Parvaneh, Nima ;
Mohammadpour, Masoud ;
Karimi, Nasser ;
Sadaghiani, Mohammad Salehi ;
Rezaei, Nima .
RESPIROLOGY, 2010, 15 (02) :289-295
[9]  
Aghamohammadi A, 2009, IRAN J PEDIATR, V19, P367
[10]   Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency [J].
Al-Herz, Waleed ;
Bousfiha, Aziz ;
Casanova, Jean-Laurent ;
Chatila, Talal ;
Conley, Mary Ellen ;
Cunningham-Rundles, Charlotte ;
Etzioni, Amos ;
Franco, Jose Luis ;
Gaspar, H. Bobby ;
Holland, Steven M. ;
Klein, Christoph ;
Nonoyama, Shigeaki ;
Ochs, Hans D. ;
Oksenhendler, Erik ;
Picard, Capucine ;
Puck, Jennifer M. ;
Sullivan, Kate ;
Tang, Mimi L. K. .
FRONTIERS IN IMMUNOLOGY, 2014, 5